Valuation
- Market cap
- 9,518,000
- Revenue TTM
- $0
- Net income TTM
- $-28,540,000
- PE ratio
- 0.00
- Forward PE
- 1.26
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 5,945,100
- Avg volume
- 8,466,812
- Day's range
- $0.19 – $0.21
- Shares out
- 47,308,000
- Stochastic %K
- 34%
- Beta
- 1.57
- Analysts
- Hold
- Price target
- $1.70
Company profile
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company was incorporated in 2009 and is headquartered in Vancouver, Canada. As of October 9, 2025, ESSA Pharma Inc. operates as a subsidiary of Alexis Bio, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 778 331 0962
- Website
- https://www.essapharma.com
- Address
- 999 West Broadway, Suite 720, Vancouver, Canada
Latest news
No headlines yet.
